A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 12, 2023
November 5, 2024
3134187f-5a62-4b96-8e62-23b17474de42
Related Documents
Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers
Guidance DocumentApril 15, 2026Center for Drug Evaluation and Research
Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier
Guidance DocumentSeptember 19, 2018Center for Drug Evaluation and Research
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry
Guidance DocumentJuly 19, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.